GSK’s £1.4bn breaks coupon records as 2012 ends on a high
GlaxoSmithKline, the UK pharmaceutical company, launched its first sterling bonds this week for nearly five years, achieving strong demand and raising £1.4bn in the second biggest corporate issue of the year in the currency.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: